Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01099384
Other study ID # 09-003981
Secondary ID R01DA025156
Status Completed
Phase Phase 1
First received April 2, 2010
Last updated May 21, 2013
Start date September 2010
Est. completion date July 2012

Study information

Verified date May 2013
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Tobacco use among adolescents is a major public health problem in the United States. The prevalence of tobacco use among adolescents is currently highest among American Indians and Alaska Natives. Among Alaska Natives residing in the Yukon-Kuskokwim (Y-K) Delta region of western Alaska, approximately 29% of 11-14 year olds, and 63% of 15-18 year olds, use tobacco. No prior work has evaluated tobacco cessation interventions for Alaska Native adolescents.

This proposal builds on the investigators successful partnership and 7 year track record of collaboration with the Y-K Delta Alaska Native community. The objective of this proposal is to develop and pilot test a novel, culturally-appropriate, behavioral treatment approach for tobacco cessation among Y-K Delta Alaska Native adolescents ages 12 to 17. The behavioral intervention will include an initial, 2 day, group-based program with follow-up support for 6 weeks. Social cognitive (learning) theory is the conceptual basis for the proposed intervention. The investigators expect that as a result of this stage I project, the investigators will have developed a replicable, feasible, and acceptable intervention, the efficacy of which can be tested in future large-scale randomized clinical trials.

This project will take place in two phases. In phase 1, the investigators will develop the intervention with feedback from a teen advisory group, and develop a counselor manual. Follow-up strategies will also be developed, pilot-tested, and refined. Twenty adolescents will complete the protocol, which will be refined in an iterative manner based on feedback from participants and counselors. Phase 2, consisting of a pilot clinical trial, will apply a group-randomized design with assessments at weeks 0 (baseline), 6, and 26. Eight villages will be randomized to receive either the behavioral intervention or control condition (written self-help materials + quitline referral). Ten adolescents will be enrolled from each village, for a total of 80 participants. The investigators will assess the feasibility and acceptability of the intervention, as determined by qualitative ratings of treatment acceptability, and recruitment and retention rates. The investigators will estimate the magnitude of the effect of the intervention compared to the control condition on the biochemically confirmed tobacco abstinence rate at weeks 6 and 26, and estimate the intra-class correlation coefficient (ICC). At week 6, the investigators will evaluate the effect of the intervention on changes from baseline on perceived social support, self-efficacy for stopping tobacco use, and other mechanisms of change consistent with the investigators theoretical framework. The overall health related objective is to develop effective treatment programs for Alaska Native youth that will ultimately reduce their risk of tobacco-related disease.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date July 2012
Est. primary completion date July 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 12 Years to 17 Years
Eligibility Inclusion Criteria:

1. Alaska Native

2. is from one of the targeted villages

3. is between 12-17 years of age

4. provides written assent

5. provides written parental consent

6. self-reports daily use of Iqmik, commercial ST, and/or cigarette smoking during the past 7 days, with current tobacco use status verified with a NicAlert salivary cotinine test strip value of >0

7. is willing to make a quit attempt

8. is willing and able to participate in all aspects of the study

9. has access to Web/e-mail and a working telephone.

Exclusion Criteria:

1. the adolescent is not able to fully participate in the intervention or would potentially pose harm to self or other group participants, and/or disrupt the group process (e.g., if subject is intoxicated at screening)

2. depression score of >16 as assessed by the Center for Epidemiological Studies Depression Scale (CES-D; Radloff, 1977)

3. current (past 3 months) participation in any tobacco pharmacological or behavioral treatment

4. another adolescent from the same household has enrolled.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Written self-help materials
Written materials to help adolescents stop tobacco use
Group behavioral counseling
group behavioral counseling (2 day weekend program)

Locations

Country Name City State
United States Yukon Kuskokwim Health Corporation Bethel Alaska

Sponsors (2)

Lead Sponsor Collaborator
Mayo Clinic Yukon Kuskokwim Health Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of recruitment Assessed at the time of screening No
Secondary Biochemically confirmed tobacco abstinence Assessed at Week 6 (End of Treatment) No
Secondary Study retention Assessed at week 24 No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Not yet recruiting NCT04501016 - A Stepped Care Approach to Treating Tobacco Use in Rural Veterans Phase 2/Phase 3
Completed NCT01570595 - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV Phase 1/Phase 2
Completed NCT01651611 - Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents N/A
Completed NCT01164306 - The Impact of a Tobacco Control Intervention in African-American Families N/A
Recruiting NCT04865276 - Adaptation and Evaluation of a Culturally and Gender Relevant Tobacco Cessation Among Women in Brazil: An Integrated mHealth Approach N/A
Recruiting NCT02103868 - Medium Vs Low Intensity Intervention in Tobacco Cessation and Control in Zari Workers N/A
Completed NCT00836199 - NicVAX/Placebo as an Aid for Smoking Cessation Phase 3
Recruiting NCT05552534 - Impact of an Intervention of Screening, Treatment Initiation and Referral to PROmote Smoking CEssation in Emergency Department Patients N/A
Completed NCT01482923 - Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations
Completed NCT05764343 - The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases N/A
Completed NCT01312480 - Adolescent Smoking Cessation in Pediatric Primary Care N/A
Completed NCT03377738 - Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care N/A
Completed NCT03096145 - Support Person Intervention to Promote a Smoking Helpline Among Under Resourced Smokers N/A
Completed NCT05095779 - Incentives for Smoking Cessation in Persistent Poverty Counties N/A
Completed NCT03062709 - A Study of Tobacco Smoke and Children With Respiratory Illnesses N/A
Completed NCT00750503 - Workplace Tobacco Cessation And Oral Cancer Screening Study Phase 3
Withdrawn NCT04340102 - Development of a Scalable Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness N/A
Completed NCT01331226 - Support Person Intervention to Promote a Smoking Helpline N/A
Completed NCT04198688 - Effectiveness of Intensive Smoking Cessation Interventions in Patients With Cancer